Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Screeners that run automatically... and then email you the results! FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Horizon Therapeutics (HZNP)

Horizon Therapeutics (HZNP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 15,544,009
  • Shares Outstanding, K 230,384
  • Annual Sales, $ 3,226 M
  • Annual Income, $ 534,490 K
  • 60-Month Beta 1.12
  • Price/Sales 4.79
  • Price/Cash Flow 10.47
  • Price/Book 3.14
Trade HZNP with:

Options Overview Details

View History
  • Implied Volatility 43.12% ( +0.90%)
  • Historical Volatility 64.91%
  • IV Percentile 58%
  • IV Rank 44.41%
  • IV High 58.22% on 08/02/22
  • IV Low 31.04% on 03/22/22
  • Put/Call Vol Ratio 0.08
  • Today's Volume 199
  • Volume Avg (30-Day) 3,014
  • Put/Call OI Ratio 0.74
  • Today's Open Interest 55,769
  • Open Int (30-Day) 37,952

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/22
See More
  • Average Estimate 1.12
  • Number of Estimates 7
  • High Estimate 1.30
  • Low Estimate 1.04
  • Prior Year 1.75
  • Growth Rate Est. (year over year) -36.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
60.76 +11.04%
on 08/03/22
87.07 -22.51%
on 07/20/22
-14.10 (-17.29%)
since 07/12/22
3-Month
60.76 +11.04%
on 08/03/22
95.39 -29.27%
on 05/31/22
-20.52 (-23.32%)
since 05/12/22
52-Week
60.76 +11.04%
on 08/03/22
120.54 -44.02%
on 11/01/21
-39.33 (-36.83%)
since 08/12/21

Most Recent Stories

More News
Company News for Aug 4, 2022

Companies in The News Are: MRNA, REGN, HZNP, EXC

REGN : 628.71 (+0.77%)
EXC : 46.17 (+1.03%)
MRNA : 171.18 (-0.37%)
HZNP : 67.47 (+0.55%)
Horizon (HZNP) Q2 Earnings Miss Estimates, Revenues Rise Y/Y

Horizon's (HZNP) earnings and revenues lag estimates in the second quarter of 2022. The company lowers full-year revenue guidance for 2022. Shares were down in pre-market trading.

BEAM : 69.08 (+4.52%)
HZNP : 67.47 (+0.55%)
ATRA : 5.84 (+25.59%)
DTIL : 2.01 (+23.31%)
Horizon Therapeutics (HZNP) Q2 Earnings and Revenues Lag Estimates

Horizon Therapeutics (HZNP) delivered earnings and revenue surprises of -20.74% and 6.65%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

HZNP : 67.47 (+0.55%)
CDXS : 8.84 (+6.00%)
Horizon Therapeutics plc Reports Second-Quarter 2022 Financial Results and Revises Full-Year 2022 Net Sales and Adjusted EBITDA Guidance

Horizon Therapeutics plc (Nasdaq: HZNP) today announced second-quarter 2022 financial results and revised its full-year 2022 net sales and adjusted EBITDA guidance.

HZNP : 67.47 (+0.55%)
Why Horizon Therapeutics (HZNP) Might Surprise This Earnings Season

Horizon Therapeutics (HZNP) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

HZNP : 67.47 (+0.55%)
Novo Nordisk (NVO) to Report Q2 Earnings: What's in the Cards?

Novo Nordisk's (NVO) top line is likely to have been driven by sales of its Diabetes and Obesity Care products in the second quarter of 2022.

NVO : 107.50 (-1.19%)
GILD : 62.96 (+0.82%)
HZNP : 67.47 (+0.55%)
BNTX : 160.35 (+1.11%)
Eli Lilly (LLY) to Report Q2 Earnings: What's in the Cards?

Higher demand for its key drugs is likely to have offset generic competition for several other drugs and may have boosted Lilly's (LLY) second-quarter sales.

LLY : 308.08 (+2.29%)
HZNP : 67.47 (+0.55%)
AMRN : 1.6500 (+2.48%)
BPMC : 72.22 (+3.59%)
Amgen (AMGN) to Report Q2 Earnings: What's in the Cards?

Volume growth from Amgen's (AMGN) key drugs like Prolia, Xgeva, Repatha, and others is expected to have been partially offset by biosimilar/generic competition for mature drugs.

AMGN : 248.39 (+0.02%)
HZNP : 67.47 (+0.55%)
AMRN : 1.6500 (+2.48%)
BPMC : 72.22 (+3.59%)
Can Horizon Therapeutics (HZNP) Keep the Earnings Surprise Streak Alive?

Horizon Therapeutics (HZNP) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

HZNP : 67.47 (+0.55%)
Cardiff Oncology (CRDF) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Cardiff Oncology (CRDF) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

CRDF : 3.04 (+0.66%)
HZNP : 67.47 (+0.55%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Horizon Therapeutics plc is a biopharmaceutical focused on making drugs in arthritis, pain, inflammatory and orphan diseases areas.

See More

Key Turning Points

3rd Resistance Point 69.73
2nd Resistance Point 68.96
1st Resistance Point 68.22
Last Price 67.47
1st Support Level 66.71
2nd Support Level 65.94
3rd Support Level 65.20

See More

52-Week High 120.54
Fibonacci 61.8% 97.70
Fibonacci 50% 90.65
Fibonacci 38.2% 83.59
Last Price 67.47
52-Week Low 60.76

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar